Proof-of-concept study on improved efficacy of rHuEPO administered as a long-term infusion in rats.

This study demonstrates that administration of rHuEPO as a long-term infusion at a rate ensuring MEC allows to achieve a high efficacy of therapy using relatively small doses of the drug.